We are live on ! Find out more
GCM

Garland Capital Management Portfolio holdings

AUM $7.27M
1-Year Est. Return 14.85%
This Fund
S&P 500
This Quarter Est. Return
+1.32%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$141M
AUM Growth
-$3.56M
Cap. Flow
-$4.7M
Cap. Flow %
-3.34%
Top 10 Hldgs %
42.17%
Holding
35
New
1
Increased
9
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$224K
2
AAPL icon
Apple
AAPL
+$205K
3
TTE icon
TotalEnergies
TTE
+$158K
4
IBM icon
IBM
IBM
+$85.9K
5
XOM icon
ExxonMobil
XOM
+$67K

Top Sells

Rank Stock Value
1
ESS icon
Essex Property Trust
ESS
+$4.2M
2
NVS icon
Novartis
NVS
+$495K
3
CSCO icon
Cisco
CSCO
+$135K
4
PEP icon
PepsiCo
PEP
+$112K
5
TRV icon
Travelers Companies
TRV
+$108K

Sector Composition

Rank Sector Weight
1 Real Estate 23.9%
2 Healthcare 22.1%
3 Financials 14.62%
4 Industrials 10.86%
5 Energy 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
1
Cisco
CSCO
$442B
$6.86M 4.88%
125,361
-2,450
-2% -$135K
PFE icon
2
Pfizer
PFE
$160B
$6.48M 4.61%
157,670
-1,950
-1% -$77.4K
JPM icon
3
JPMorgan Chase
JPM
$942B
$6.37M 4.52%
56,940
-300
-0.5% -$33.1K
MRK icon
4
Merck
MRK
$369B
$6.14M 4.36%
76,705
PG icon
5
Procter & Gamble
PG
$333B
$6.09M 4.33%
55,565
-37
-0.1% -$3.94K
UNP icon
6
Union Pacific
UNP
$183B
$5.8M 4.12%
34,278
-550
-2% -$94.2K
JNJ icon
7
Johnson & Johnson
JNJ
$640B
$5.71M 4.06%
41,007
-125
-0.3% -$17.3K
TRV icon
8
Travelers Companies
TRV
$77B
$5.36M 3.81%
35,825
-750
-2% -$108K
CVX icon
9
Chevron
CVX
$392B
$5.34M 3.8%
42,950
-25
-0.1% -$3.02K
PLD icon
10
Prologis
PLD
$135B
$5.19M 3.69%
64,795
-725
-1% -$55.2K
RTX icon
11
RTX Corp
RTX
$286B
$5.17M 3.67%
63,059
-120
-0.2% -$10K
PEP icon
12
PepsiCo
PEP
$191B
$5.15M 3.66%
39,247
-875
-2% -$112K
LPT
13
DELISTED
Liberty Property Trust
LPT
$5.04M 3.58%
100,615
-700
-0.7% -$34.3K
NVS icon
14
Novartis
NVS
$294B
$5.02M 3.57%
54,940
-5,843
-10% -$495K
WELL icon
15
Welltower
WELL
$173B
$4.96M 3.52%
60,770
-375
-0.6% -$29.5K
PRU icon
16
Prudential Financial
PRU
$41.5B
$4.95M 3.52%
49,050
+475
+1% +$47.4K
ARE icon
17
Alexandria Real Estate Equities
ARE
$9B
$4.64M 3.3%
32,915
-300
-0.9% -$43.3K
MMM icon
18
3M
MMM
$92.2B
$4.32M 3.07%
29,810
-240
-0.8% -$36.9K
IBM icon
19
IBM
IBM
$225B
$4.3M 3.05%
32,605
+654
+2% +$85.9K
ABBV icon
20
AbbVie
ABBV
$456B
$4.25M 3.02%
58,420
-755
-1% -$59.3K
PSA icon
21
Public Storage
PSA
$58.1B
$4.04M 2.87%
16,948
T icon
22
AT&T
T
$174B
$3.99M 2.84%
157,809
-165
-0.1% -$3.96K
XOM icon
23
ExxonMobil
XOM
$643B
$3.98M 2.83%
51,882
+865
+2% +$67K
BNY
24
Bank of New York Mellon
BNY
$110B
$3.9M 2.77%
88,350
+1,100
+1% +$51.7K
CVS icon
25
CVS Health
CVS
$119B
$3.51M 2.49%
64,400
+4,160
+7% +$224K

Similar funds

Garland Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Garland Capital Management held 35 positions worth $141M, down 2.5% from $144M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Garland Capital Management withdrew a net $4.7M in Q2 2019, closing 1 position and reducing 20 holdings. Its most notable exit was Essex Property Trust, an estimated $4.2M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Garland Capital Management opened a new position in Apple worth $208K.

  • Garland Capital Management's largest Q2 2019 buy was Apple: 4,200 shares worth $208K.
  • Garland Capital Management added most to CVS Health in Q2 2019, an estimated $224K increase.
  • Garland Capital Management's biggest Q2 2019 reduction was Novartis, cutting an estimated $495K.
  • Garland Capital Management fully exited Essex Property Trust in Q2 2019, selling an estimated $4.2M.
  • Garland Capital Management's ten largest holdings make up 42% of its $141M portfolio in Q2 2019.
  • Garland Capital Management opened 1 new position and closed 1 in Q2 2019.
  • Garland Capital Management's portfolio value fell 2.5% quarter-over-quarter to $141M.

Based on Garland Capital Management's 13F filing for Q2 2019, filed 24 Jul 2019.